Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Heart Failure Medication

Research Leaders

5 sponsors active, led by University Hospital Homburg/Saar

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05636774Not ApplicableCompletedPrimary

Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial

Showing all 1 trials

Research Network

Common Treatments

  • Heart Failure Medication1

Active Sponsors

  • University Hospital Homburg/Saar1
  • Universitätsklinikum Leipzig1
  • University Hospital, Essen1
  • Charite University, Berlin, Germany1
  • University Hospital Heidelberg1

Top Investigators

Activity Timeline